Palvella Therapeutics (PVLA) Return on Capital Employed (2016 - 2024)
Historic Return on Capital Employed for Palvella Therapeutics (PVLA) over the last 10 years, with Q3 2024 value amounting to 0.2%.
- Palvella Therapeutics' Return on Capital Employed rose 10200.0% to 0.2% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.2%, marking a year-over-year increase of 10200.0%. This contributed to the annual value of 0.24% for FY2023, which is 2500.0% up from last year.
- Palvella Therapeutics' Return on Capital Employed amounted to 0.2% in Q3 2024, which was up 10200.0% from 0.15% recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Return on Capital Employed ranged from a high of 0.2% in Q3 2024 and a low of 1.12% during Q1 2023
- Its 5-year average for Return on Capital Employed is 0.42%, with a median of 0.48% in 2021.
- Per our database at Business Quant, Palvella Therapeutics' Return on Capital Employed tumbled by -6100bps in 2023 and then surged by 12900bps in 2024.
- Palvella Therapeutics' Return on Capital Employed (Quarter) stood at 0.38% in 2020, then dropped by -24bps to 0.48% in 2021, then tumbled by -50bps to 0.72% in 2022, then surged by 47bps to 0.38% in 2023, then surged by 152bps to 0.2% in 2024.
- Its last three reported values are 0.2% in Q3 2024, 0.15% for Q2 2024, and 0.17% during Q1 2024.